Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in the European […]
Group sales increase 3%1 at constant exchange rates (CER); 1% decline in Swiss francs, as a result of the appreciation of the Swiss franc Pharmaceuticals […]
The technology used in some Covid-19 doses could facilitate different vaccines or treatments for certain cancers. These advances need the firm and constant support of […]
New partnership aims to provide farmers with new high-potential wheat varieties, enhancing sustainable agricultural practices RAGT and Bayer have entered an exclusive collaboration to jointly […]
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® PDF Version European Union exercises option under previous agreement to […]
Merck, a leading science and technology company, today announced an investment of EUR 20 million to expand research and development and manufacturing capabilities at its […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today requested amendments to the U.S. Emergency Use Authorization (EUA) of the Pfizer-BioNTech vaccine (BNT162b2) to […]
The vaccination strategy will pick up pace in the coming weeks, with a gradual and steady increase towards the end of the summer. The vaccination […]
…Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective […]
Copyright © 2023 | WordPress Theme by MH Themes
